Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys by Asselman, M. (Marino) et al.
Calcium Oxalate Crystal Adherence to Hyaluronan-,
Osteopontin-, and CD44-Expressing Injured/Regenerating
Tubular Epithelial Cells in Rat Kidneys
MARINO ASSELMAN,* ANJA VERHULST,† MARC E. DE BROE,† and
CARL F. VERKOELEN*
*Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands; and †Department
of Nephrology-Hypertension, University of Antwerp, Antwerp, Belgium
Abstract. Retention of crystals in the kidney is an essential
early step in renal stone formation. Studies with renal tubular
cells in culture indicate that hyaluronan (HA) and osteopontin
(OPN) and their mutual cell surface receptor CD44 play an
important role in calcium oxalate (CaOx) crystal binding dur-
ing wound healing. This concept was investigated in vivo by
treating rats for 1, 4, and 8 d with ethylene glycol (0.5 and
0.75%) in their drinking water to induce renal tubular cell
damage and CaOx crystalluria. Tubular injury was morpholog-
ically scored on periodic acid-Schiff–stained renal tissue sec-
tions and tissue repair assessed by immunohistochemical stain-
ing for proliferating cell nuclear antigen. CaOx crystals were
visualized in periodic acid-Schiff–stained sections by polarized
light microscopy, and renal calcium deposits were quantified
with von Kossa staining. HA was visualized with HA-binding
protein and OPN and CD44 immunohistochemically with spe-
cific antibodies and quantified with an image analyzer system.
Already after 1 d of treatment, both concentrations of ethylene
glycol induced hyperoxaluria and CaOx crystalluria. At this
point, there was neither tubular injury nor crystal retention in
the kidney, and expression of HA, OPN, and CD44 was com-
parable to untreated controls. After 4 and 8 d of ethylene
glycol, however, intratubular crystals were found adhered to
injured/regenerating (proliferating cell nuclear antigen posi-
tive) tubular epithelial cells, expressing HA, OPN, and CD44
at their luminal membrane. In conclusion, the expression of
HA, OPN, and CD44 by injured/regenerating tubular cells
seems to play a role in retention of crystals in the rat kidney.
The development of kidney stones requires formation of crys-
tals followed by their retention in the kidney (1). Crystal
retention could be caused by adherence of crystals to the
epithelial cells lining the renal tubules (2). Although many
investigators recognized a role for renal tubular injury in the
pathophysiology of nephrolithiasis, definite proof for this con-
cept and the mechanisms involved are not yet available (3–7).
Most kidney stones are predominantly composed of precip-
itated calcium salts, the most common of which is calcium
oxalate monohydrate (5). Studies with renal tubular epithelial
cells in culture showed that confluent monolayers of distal
tubule/collecting duct–like MDCK-I cells are nonadherent to
calcium oxalate monohydrate crystals (8). In contrast, crystals
bind to cells in subconfluent cultures and in confluent mono-
layers recovering from mechanical injury (9). The glycosami-
noglycan hyaluronan (HA) was identified as a major crystal-
binding molecule at the surface of MDCK-I cells (10) and of
human renal tubular cells in primary culture (11). In addition, it
was found that crystal-binding cells not only expressed HA at
their apical surface but also osteopontin (OPN) and CD44 (11).
HA is a high molecular mass polysaccharide (106 Da),
composed of linear polymers of a repeating disaccharide struc-
ture of alternating glucuronic acid and N-acetylglucosamine. In
the kidney, HA is hardly detectable in the cortex but is abun-
dantly present as the main component of the renal inner med-
ullary interstitium (12). HA in the kidney is upregulated during
various inflammatory disease states (13–17). OPN is a glyco-
protein and is widely spread throughout organs and tissues,
including the kidney. In the healthy kidney, OPN is confined to
the distal parts of a subset of nephrons. During various types of
inflammation, however, renal OPN is severely upregulated in
most segments of the nephron (13,14,18–20). The transmem-
brane protein CD44 is a cell surface receptor for both HA and
OPN (21,22) and also is upregulated during inflammation in
the kidney (13,14). The present study was conducted to inves-
tigate whether in vivo renal tubular injury and HA, OPN, and
CD44 expression are involved in crystal retention.
Materials and Methods
Experimental Design
Male Wistar rats (300 to 350 g) were obtained from the Central
Animal Breeding Center (Harlan, Zeist, the Netherlands) and divided
into three groups (n  9 each) receiving drinking water supplemented
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with 0, 0.5, or 0.75% (vol/vol) ethylene glycol (EG) for 1, 4, and 8 d.
All animals had free access to standard chow. Twenty-four hours
before the indicated times, rats were housed individually in metabolic
cages to collect 24-h urine samples and to monitor fluid intake. Urine
samples were divided into portions of 5 ml, one portion of which was
acidified with 100 l of 1 M hydrochloric acid and stored at 20°C
until analysis. Animals were sedated and killed; kidneys were ex-
tracted and decapsulated; and sagittal slices were immediately fixed in
either methacarn (60% methanol, 30% chloroform, 10% acetic acid)
or Dubosq-Brasil fixative (47% ethanol, 11.7% H2O, 23.5% formal-
dehyde, 17.6% acetic acid, and 4 mM picric acid) for 4 h, rinsed with
70% ethanol, and embedded in low-melting-point paraffin (52°C;
BDH Laboratory Supplies, Poole, UK). Serum specimens were col-
lected and frozen at 20°C until biochemical analysis. The experi-
ments were approved by the local University Animal Committee and
carried out in accordance with the Netherlands Experiments on Ani-
mals Act (1977) and the European Convention for the Protection of
Vertebrate Animals Used for Experimental Purposes (Strasbourg,
March 18, 1986).
Urine and Serum Biochemistry
Urinary oxalate was determined in acidified urine portions with a
quantitative enzymatic colorimetric assay (Sigma Diagnostics, Dei-
senhofen, Germany). For determination of urinary citrate, the ultra-
violet method with the test combination of Boehringer Mannheim
(Darmstadt, Germany) was used. The concentrations of calcium in
urine and bicarbonate, calcium, and creatinine in serum were deter-
mined on a routine autoanalyzer system (Vitros 750 XRC). Urine
samples were centrifuged at 5000  g, and sediments were inspected
by optical and polarized light microscopy (Zeiss Axioplan micro-
scope, Oberkochen, Germany).
Tubular Morphology
Methacarn-fixed, paraffin-embedded renal tissue sections (4 m)
were stained with periodic acid-Schiff (PAS), and nuclei were coun-
terstained with methyl green. Histologic damage was evaluated with
a morphologic scoring system (Table 1) in proximal tubules (PT), thin
limbs of Henle (TLH), distal tubules (DT; including thick ascending
limbs [TAL]) and collecting ducts (CD). Tubules were morphologi-
cally inspected by a reproducible procedure, which comprised a
random selection of the first tubular cross-section, followed by shift-
ing the microscopic field over fixed distances according to a stan-
dardized pattern (300 magnification). The cortex, outer stripe of the
outer medulla (OSOM), inner stripe of the outer medulla (ISOM), and
inner medulla of each kidney section were evaluated. In the cortex, PT
(S1–S2) and DT were evaluated (n  50 and 25, respectively); in the
OSOM, PT (S3) and DT (TAL) were evaluated (n  50 and 25,
respectively); in the ISOM, TLH and DT (TAL) were evaluated (n 
25 each); and in the inner medulla, TLH and CD were evaluated (n 
25 each). PT and DT could be distinguished according to at least one
of the following morphologic criteria: topographical localization, tu-
bular size and form, cytoplasmic density and position of the nuclei,
and presence or absence of brush border and basolateral cell aspect.
Tubules in the cortex and OSOM were scored as PT only when a
brush border could be identified; if not, then they were scored as DT.
In the ISOM and inner medulla, TLH could be distinguished from DT
(TAL) and CD by tubular size and position of the nuclei.
Proliferation was determined by immunohistochemical staining for
proliferating cell nuclear antigen (PCNA) using the PC10 mAb
(DAKO, Glostrup, Denmark) as described previously (23). Routinely,
sections were counterstained with PAS and nuclei were stained with
methyl green. In a number of sections, PAS staining was omitted,
allowing optimal visualization of crystals. Expression of PCNA was
quantified morphometrically with an image analyzer system (KS-400
V2.0 image analysis software) in the cortex  OSOM and ISOM 
inner medulla, by measuring positive signals in 25 and 15 randomly
chosen microscopic fields, respectively (250 magnification). Mea-
surements were expressed as fractional positive area of the tissue
section.
Crystal Retention
During the evaluation of tubular morphology, each tubule was
additionally inspected by polarized light microscopy for the presence
of crystals. In this way, crystal retention was assessed and sites of
crystal location were correlated with tubular morphology.
Calcium deposits were also visualized by von Kossa staining.
Deparaffinized Dubosq-Brasil–fixed 4-m tissue sections were incu-
bated in 5% silver nitrate for 45 min. Slides were rinsed in water,
incubated in 1% pyrogallic acid for 3 min, rinsed in water, fixed in 5%
sodium thiosulfate for 1 min, and counterstained with hematoxylin
and eosin. In each sagittal kidney section, calcium deposits were
quantified by counting the total number of positive stained crystals in
the cortex  OSOM and ISOM  inner medulla.
HA, OPN, and CD44 Expression
Renal tissue sections were stained for HA, OPN, and CD44 as
described previously (11). Briefly, methacarn-fixed tissue sections
were blocked with 1% BSA for HA and with normal horse serum for
OPN and CD44 staining and incubated with primary labels (biotin-
ylated HA-binding protein, Seikagaku, Falmouth, MD; goat anti-
human OPN antibody, OP189, C.M. Giachelli, University of Wash-
ington; or mouse anti-human CD44 antibody, Bender MedSystems,
Vienna, Austria). For OPN and CD44, sections were subsequently
incubated with secondary labels, biotinylated horse anti-goat and
horse anti-mouse antibodies (Vector Laboratories, Burlingame, CA),
respectively. Finally, avidin-biotin peroxidase complex (Vector) and
diaminobenzidine were used to detect HA, OPN, and CD44. Sections
were counterstained with methyl green. No staining was observed
when primary labels were omitted.
Table 1. Scoring system for the evaluation of tubular morphology of PT, TLH, DT (including TAL), and CDa
Score PT TLH DT (TAL)/CD
0 Intact tubule with normal appearance Intact tubule with normal appearance Intact tubule with normal appearance
1 Tubule with luminal cell debris Tubule with luminal cell debris Tubule with luminal cell debris
2 Tubule with loss of brush border – Dilated tubule
3 Tubule with flattened cells – Tubule with flattened cells
a PT, proximal tubules; TLH, thin limbs of Henle; DT, distal tubules; TAL, thick ascending limbs; CD, collecting ducts.
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Expression of HA, OPN, and CD44 was quantified morphometri-
cally with KS-400 V2.0 image analysis software in the cortex and
OSOM, by measuring positive signals in 10 and six randomly chosen
microscopic fields, respectively (200 magnification). Measurements
were expressed as fractional positive area of the tissue section. OPN
and CD44 were also quantified in the remaining part of the medulla,
by analyzing six randomly chosen microscopic fields of the ISOM and
inner medulla. HA was not quantified in this region, because the well
known abundant amount of HA in the interstitium of the inner
medulla stains nearly the entire tissue (12).
Statistical Analyses
Data are expressed as mean  SEM. P  0.05 was considered to
be significant, using t test. Correlation analysis between total tubular
PCNA expression per sagittal kidney section and the total amount of
Figure 1. Urine- and serum biochemical analysis, urine production, and fluid intake. Statistical analysis by t test. *Significantly different
compared with controls at the same point in time (P  0.05).
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positive von Kossa renal calcium deposits per sagittal kidney section
in individual rats was performed by the nonparametric Spearman’s
rank order test. P  0.01 was considered significant (two-tailed).
Computations were performed using SPSS version 10.
Results
Urine and Serum Biochemistry
In the control group, the average urinary oxalate and calcium
excretion was 0.95  0.05 and 3.24  0.79 mg/24 h, respec-
tively (Figure 1), and the urinary sediment did not contain
crystals (Figure 2A). Administration of 0.5 and 0.75% EG to
the drinking water induced within 24 h a significant concen-
tration-dependent hyperoxaluria (4.37  1.71 and 7.78  4.46
mg/24 h, respectively). In the 0.5% EG group, oxalate gradu-
ally increased further to reach its maximum level at day 8,
whereas in the 0.75% EG group, urinary oxalate reached its
maximum level already at day 4. Urinary calcium was de-
creased at day 1 and was undetectable at day 4 and day 8
(Figure 1). At day 1, calcium oxalate crystals were observed in
urinary sediments of both EG groups (Figure 2B). Oxalate was
determined in acidified urine portions, which dissolves crystals
and therefore represents the total amount of oxalate, including
oxalate precipitated with calcium. Because calcium was deter-
mined in urine that was not acidified, it represents the amount of
free calcium ions. Thus, the decreased amounts of urinary calcium
apparently resulted from the formation of CaOx crystals.
In the 0.5% EG group at day 8 and in the 0.75% EG group
at days 4 and 8, increased diuresis and fluid intake were
observed compared with controls. Thus, the addition of EG led
to polyuria, which may be secondary to the osmotic effect of
EG excreted in the urine unchanged (24) or simply because
these rats drank more water (Figure 1). There was no increase
in serum creatinine, except for a slight increase in the low-dose
EG at day 8, indicating that renal function was preserved in
these rats. These biochemistry data are in accordance with
earlier observations in rats treated with EG (25).
EG caused a metabolic acidosis, as can be derived from the
concentration-dependent decrease in urinary citrate after 4 d.
This metabolic acidosis was relatively mild, however, as serum
bicarbonate and calcium were not affected and a compensatory
homeostatic response seemed to normalize urinary citrate after
continued EG challenge (Figure 1).
Tubular Morphology
The relatively low concentrations of EG in the present study
did not result in frank necrosis but in mild changes in tubular
morphology. At day 1, tubular morphology was comparable to
controls, but at days 4 and 8, different degrees of injury/
regeneration were found in tubules (Figure 3). PT of the
OSOM (S3) and, to a lesser extent, PT in the cortex (S1–S2)
suffered the most morphologic damage, for the most part with
loss of brush border (score 2). Tubules with flattened cells
(score 3) were also observed, predominantly in DT (TAL) of
the OSOM. Because a tubule with flattened cells was scored
only as PT if there was still brush border recognizable, the
number of PT with score 3 could actually have been higher. In
TLH and CD at days 4 and 8, increased amounts of luminal cell
debris (score 1) were observed, but the majority of these tubules
had a normal morphology (score 0). Importantly, cell debris in the
tubular lumen in the distal nephron could also have been derived
from an “upstream” section of the nephron, and the tubule con-
cerned could actually have been completely healthy.
At day 1, PCNA staining was comparable to control kidneys,
in which tubular expression of this protein was sparse (Figure
4A), whereas at days 4 and 8, PCNA staining was clearly
upregulated in tubules in rats that received EG (Figure 4B).
Crystal Retention
No crystals were found in control rat kidneys (Figure 5).
After 1 d of 0.5 and 0.75% EG, no crystals were observed by
polarized light microscopy, consistent with a marginal amount
of positive von Kossa signals. At days 4 and 8, however, an
increasing number of crystals were found attached to the lu-
minal membrane of tubular epithelial cells, corresponding with
a markedly increased number of positive von Kossa signals
Figure 2. Urinary sediment inspected by polarized light microscopy of
a control rat (A) and a 0.5% ethylene glycol (EG)-treated rat (B) after
1 d. (A) Some debris was observed, but no urinary crystalline mate-
rial. (B) Numerous urinary calcium oxalate crystals in the EG-treated
rat are clearly visible. Magnification, 400.
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(Figure 5). Crystals were smaller in size than the tubular lumen
and not seen intracellularly or in the interstitium.
In Figure 6, retention of crystals and tubular morphology
is plotted in a graph. In PT, DT (TAL), and CD, crystals
were not observed in histologic normal tubules (score 0) or
tubules with luminal cell debris (score 1). Crystals were
found adhered to tubular cells in PT with loss of brush
border and DT (TAL) and CD with dilation of the tubular
lumen (score 2), and in tubules with flattened cells (score 3).
Crystals were not observed in TLH (data not shown). Figure
Figure 3. Evaluation of tubular morphology with the scoring system of Table 1 in proximal tubules (PT), thin limbs of Henle (TLH), distal
tubules (DT; including thick ascending limbs [TAL]), and collecting ducts (CD 0  intact tubule with normal appearance, 1  tubule with
luminal cell debris, 2  PT: tubule with loss of brush border/DT (TAL) and CD: dilated tubule, 3  tubule with flattened cells).
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7 shows a DT with small crystals at the luminal membrane
of flattened tubular epithelial cells (score 3). Furthermore,
these flattened cells were PCNA positive, proliferating cells
(Figure 4, C and D). Approximately 93% of the observed
crystals in PCNA-stained renal tissue sections were found to
be adhered to PCNA-positive cells.
Correlation analysis was performed between the total
amount of tubular PCNA expression and the amount of posi-
tive von Kossa calcium deposits in sagittal kidney sections of
individual rats (Figure 8). Tubular cell regeneration was asso-
ciated with crystal adhesion/retention (Spearman’s Rho 
0.819; P  0.0001).
HA, OPN, and CD44 Expression
HA in the cortex and OSOM of control rats was scarcely
observed in the interstitium and around a few glomerular
Figure 4. Proliferating cell nuclear antigen (PCNA) staining in a kidney of a control rat (A) and of a rat that received 0.75% EG for 8 d (B
through D). In D, periodic acid-Schiff (PAS) counterstaining was omitted. (A) Sparse PCNA staining, mainly present in the interstitium and
glomeruli in a control rat. (B) Strongly upregulated PCNA in the tubules of an EG-treated rat. (C and D) Crystals associated with
PCNA-positive, flattened cells. Magnifications: 400 in A, 200 in B, 630 in C and D.
Figure 5. Quantification of renal calcium deposits on von Kossa–stained tissue sections.
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capsules. After 1 d, HA expression in EG-treated rats was
comparable to controls (Figure 9). After 4 and 8 d, however,
HA was upregulated in a focal pattern throughout the cortex
and OSOM of EG-treated rats (Figure 9), primarily in the
interstitium but also at the luminal membrane of tubular cells
(Figure 10A). Strikingly, in the majority of cases, crystals were
found at the luminal surface of HA-expressing cells (Figure
10A).
OPN was expressed in a limited number of distal tubular
epithelial cells of control rats. After 1 d of EG, OPN expression
was not different from controls, except for a small increase in
the OSOM of the moderate-dose EG group (Figure 9). At days
4 and 8, however, OPN was significantly upregulated in the
kidneys of EG-treated rats (Figure 9). Both PT and DT showed
a rise in OPN immunostaining (Figure 10, B and C). The
classical OPN expression pattern was observed, with Golgi
apparatus immunostaining in PT and at the apical membrane in
DT, allowing differentiation between PT and DT (previously
described after renal ischemia/reperfusion) (19,26). Crystals
were retained in apical OPN-expressing DT. Crystals were
positive for OPN, which was evident by comparison between
optical and polarized light microscopy (Figure 10, B and C).
Figure 6. Retention of crystals in relation to tubular morphology. In PT, DT (including TAL), and CD, crystals were not observed in tubules
with score 0 (normal appearance) or score 1 (luminal cell debris). Crystals were exclusively retained at the luminal surface of tubular cells in
PT, DT, and CD with score 2 (loss of brush border in PT and dilated tubules in DT and CD) and score 3 (tubules with flattened cells).
Figure 7. PAS and methyl green–stained renal tissue section of a rat treated with 0.75% EG for 4 d by optical (A) or polarized (B) light
microscopy. (A) A dilated DT is shown with flattened epithelial cells (score 3). (B) In the lumen of this DT, crystals that are smaller than the
tubular lumen are clearly visible and located at the luminal side of the injured/regenerating flattened epithelium. Magnification, 1000.
Figure 8. Correlation analysis was performed between the total
amount of tubular PCNA expression and the amount of positive von
Kossa calcium deposits in sagittal kidney sections of individual rats
(Spearman’s Rho  0.819, P  0.0001).
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CD44 was hardly expressed in the rat kidney, except for
some interstitial cells and glomeruli. After 1 d of EG, CD44
expression was not significantly different from controls (Figure
9). After 4 and 8 d of EG, however, CD44 in the cortex,
OSOM, and medulla was markedly upregulated (Figure 9).
CD44 expression was prominent in a focal pattern along ba-
solateral and apical tubular cell membranes (Figure 10D).
Crystals were observed frequently closely at sites where cells
expressed CD44 at their luminal membrane (Figure 10D).
Discussion
In the present study, we investigated the role of HA, OPN,
and CD44 in retention of crystals in renal tubules damaged by
EG. The EG model is extremely suitable for this purpose since
this agent not only is toxic to the nephron but also generates
urinary CaOx crystals (25,27–30). For investigating the earliest
events involved in crystal retention, these studies were per-
formed shortly (1, 4, and 8 d) after the addition of EG to the
drinking water and at relatively low concentrations to avoid
massive tissue damage. One of the major findings was that
there is no crystal retention in the absence of tubular injury/
regeneration but that crystals are retained as soon as renal
tubules are injured/regenerating. Crystals were found adhered
to the luminal surface of HA-, OPN-, and CD44-expressing
injured/regenerating cells. The results of this study therefore
strongly suggest that crystal retention in the kidney requires
tubular epithelial injury accompanied by luminal expression of
HA, OPN, and CD44.
EG, which itself is not nephrotoxic, is metabolized in the
liver to several intermediates, including glycoaldehyde, glyco-
late, glyoxylate, and oxalate (27). It is still a matter of debate
which of these metabolites are responsible for the damage to
renal tubular cells (28,29). Oxalate precipitates as CaOx in the
primary urine as a result of its poor solubility. The nephrotoxic
effect of EG has also been attributed to these crystals (25,31).
However, autopsy and renal biopsy studies in humans did not
support the concept that crystals are the primary cause of EG
toxicity (27). Considering this controversy, it is impossible in
the present study to distinguish between crystals binding to
injured/regenerating cells and the alternative explanation that
crystal deposition causes cell injury (and consequently cells
bind crystals). Crystals did not seem to be retained because of
their size, because no crystal aggregates occluding the tubular
lumen were observed, but crystals were generally smaller
(Figures 4, C and D, 7, A and B, and 10, A, B, C, and D).
In urolithiasis research, animals are usually treated with
relatively high concentrations of EG for several weeks
(25,30,31). Also in these studies, crystals are retained in tu-
Figure 9. Quantification of renal hyaluronan (HA), osteopontin (OPN), and CD44 expression using computerized image analysis software
(KS400). Data are expressed as fractional positive area (%). Statistical analysis by t test. *Significantly increased compared with controls at
the same point in time (P  0.05).
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bules that are clearly injured (25,31,32). In the present study,
the short period of treatment (1 to 8 d) with relatively low
concentrations of EG did not result in frank necrosis or cast
formation but in a mild form of injury/regeneration. Renal
tubular injury was morphologically scored (see Table 1), and
PCNA was used to assess cell proliferation. PCNA is an
auxiliary protein for DNA polymerase  and required for both
DNA replication and DNA repair. In proliferating cells, it is
upregulated in cell nuclei mainly during the S-phase (DNA
synthesis phase) of the cell cycle (33). Consequently, it is
widely used as a marker for proliferating cells. Immunohisto-
chemical PCNA staining is a validated method for evaluating
epithelial regeneration of the kidney after renal damage (23). It
is well known that in the kidney, tubular cell injury and
regeneration occur concurrently (23). Hence, the flattened,
PCNA-positive tubular cells after 4 and 8 d of EG treatment
(Figure 4B) are dedifferentiated proliferating cells.
HA is a high molecular mass polysaccharide found in many
tissues, where it performs a great range of biologic functions
(34,35). In the kidney, HA is normally not expressed at the
luminal surface of tubular cells and is present only in the
medullary interstitium, where it provides structural stability to
the tubules and contributes to concentrating the urine (12). HA
expression in the renal cortex is upregulated in renal inflam-
matory diseases such as interstitial nephritis (13), acute isch-
emic injury (14,17), autoimmune renal injury (15), and acutely
rejecting human kidney grafts (16). HA accumulates in
wounded tissue shortly after injury to form loose hydrated
matrices that allow cell division and migration (36,37). During
recent years, we searched extensively for crystal-binding mol-
ecules at the surface of renal tubular cells in culture
(10,11,38,39). HA was identified as major crystal-binding sub-
stance, based on the following results: (1) crystals bind to
HA-expressing cells at subconfluence but not to cells in con-
Figure 10. (A) The outer stripe of the outer medulla (OSOM) stained for HA of a rat with 0.75% EG in the drinking water for 8 d. HA is
upregulated in the interstitium as well as at the apical membrane of tubular epithelial cells. A crystal is shown close to cells that express HA
at their luminal membrane. (B and C) The OSOM stained for OPN after 8 d of 0.75% EG, showing increased typical Golgi apparatus
immunostaining in PT and at the apical cell membrane in DT. (C) Crystals visualized with polarized light microscopy. Retained crystals stained
for OPN are smaller than the tubular lumen and closely associated with apical OPN-expressing epithelium. (D) The cortex stained for CD44
after 8 d of 0.75% EG. CD44 is upregulated at basolateral and apical tubular cell membranes. Polarized light microscopy shows birefringent
crystals in the lumen of a tubule closely associated with the surface of flattened cells positive for CD44. Magnification, 1000.
J Am Soc Nephrol 14: 3155–3166, 2003 Crystal Retention in Injured Rat Kidneys 3163
fluent cultures that do no longer express HA; (2) metabolic
labeling studies showed that the surface of proliferating cells
contains substantially higher levels of radiolabeled HA; (3)
crystal binding could be decreased by Streptomyces hyaluron-
idase, an enzyme that specifically digests HA; and (4) during
wound healing, HA-binding protein binds to migrating and
proliferating flattened cells in damaged areas but not to cells in
intact monolayers (10). The co-localization of intraluminal
CaOx crystals with HA-expressing tubular cells in the present
study suggests for the first time, to our knowledge, a role for
HA in crystal retention in vivo.
The glycoprotein OPN is widely distributed in the body and
has been implicated in several physiologic and pathologic
processes, including cell adhesion, migration, signaling, in-
flammation, and biomineralization (18,40,41). In the kidney,
the expression of OPN is upregulated during renal injury
(18,19,42), including induced by EG (31). The role of OPN
under these circumstances is unclear, but OPN seems to be
involved in mediating macrophage accumulation and intersti-
tial fibrosis (18,43). The role of OPN in urolithiasis is contro-
versial. OPN has been proposed as an inhibitor of crystal
formation and retention but also as a promoter of crystal
retention (44–46). Recently, crystal retention was studied in
OPN knockout and wild-type mice treated with EG (44).
Noticeably, after 4 wk of treatment with 1% EG, no crystals
were retained in wild-type mice, whereas some crystal reten-
tion was observed in the kidneys of OPN knockouts (14.3  3
von Kossa signals per sagittal kidney section). From these
observations, the authors concluded that OPN protects the
kidney from crystal formation and retention. However, the
crystal retention inhibitor function of OPN seems to be inef-
fective in the present study, because crystals covered with OPN
but smaller in size than the tubular lumen became firmly
associated with the cell surface (Figure 10, B and C). This is in
agreement with a previous study, in which it was demonstrated
that urinary inhibitors of crystallization were unable to prevent
the attachment of crystals to regenerating renal tubular cells
(47). Consequently, possibly because of the differences in
species and study designs between the present study and the
one performed by Wesson et al. (44), the role of OPN remains
controversial.
CD44 is a ubiquitous transmembrane glycoprotein that is
involved in many processes including inflammation (48).
CD44 serves as cell surface receptor for both HA and OPN
(21,22). In fact, the biologic activity of HA and OPN predom-
inantly depends on their interaction with CD44 (49–51). In the
kidney, the expression of CD44 is highly upregulated during
various renal disease states (13,14). Hence, it is not surprising
that an upregulated expression of CD44 in the renal tubules is
accompanied by an increased expression of its ligands HA and
OPN. Reports of the role of CD44 in renal stone formation are
scarce. In cell culture, it was found that CD44 is expressed at
the luminal surface of crystal-binding renal tubular cells but
not on that of cells without affinity for crystals (11). In the
present study, crystals were also retained at sites where cells
expressed CD44. In our opinion, crystals are not likely to
become associated with CD44 but rather with HA and/or OPN.
The present study supports in vivo for the first time the
concept that crystal retention is associated with HA expressed
at the luminal surface of injured/regenerating cells. However,
we cannot rule out the importance of other crystal-binding
molecules, including sialic acid–containing glycoproteins (52),
phosphatidyl serine (53), collagen (54), and nucleolin-related
protein (55). Furthermore, several other macromolecules have
been implicated in CaOx crystallization and retention (56),
including inter- inhibitor–related proteins (32) such as
bikunin (57) and prothrombin fragment 1 (58). Although in the
present study we focused on HA, OPN, and CD44, the inter-
relationship between these and other molecules as part of
complex cell biologic pathways in the pathophysiology of
kidney stone disease remains to be determined (2).
Although the expression of HA, OPN, and CD44 by injured/
regenerating tubular epithelial cells most likely is aimed to
reestablishment of the epithelial barrier integrity and restora-
tion of renal function, a negative side effect could be that it
turns a non–crystal-binding epithelium into a crystal-binding
one, thereby setting the stage for crystal retention (Figure 11).
Figure 11. Paradigm of crystal retention. A schematic representation
of a cross-section of a distal tubule is shown. (A) Under normal
conditions, crystals do not bind to renal tubular epithelial cells and are
harmlessly excreted in the urine. (B) Crystal retention is preceded by
a stressor injuring the epithelium. (C) During the process of tubular
epithelial regeneration and repair, flattened epithelial cells express
HA, OPN, and CD44 at their apical membrane. HA is a cell surface
crystal-binding molecule. Because these regenerating dedifferentiated
tubular epithelial cells are susceptible to crystal binding, crystal re-
tention may ensue.
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The clinical relevance of this concept was recently reinforced
by observations in kidneys of preterm neonates, in which the
development of nephrocalcinosis is common, showing that HA
and OPN are abundantly expressed at the luminal membrane of
proliferating tubular cells (unpublished results).
In conclusion, the results obtained in this study support the
concept that the expression of HA, OPN, and CD44 by injured/
regenerating tubular cells is a prerequisite for retention of
crystals in the kidney.
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